Digital Health In Brief

American Telemedicine Association plans consumer education push. Institute of Medicine sets August telehealth workshop. More digital health news.

The American Telemedicine Association used its ATA 2012 conference in San Jose, Calif., to help gather financial support for a planned push to build consumer awareness of telemedicine. At a May 1 keynote session, ATA President-elect Stewart Ferguson challenged conferees to stand up and commit to donating money towards a prize for the best 60-second consumer education video on the topic. Officials from several telemedicine technology companies, including MicroTech and GlobalMed, each pledged $5,000-$10,000.

Ferguson practices telemedicine in Alaska, where demand for the technology is high. “One of the biggest challenges is once you build it and do all of the effort, suddenly sometimes...

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight